# Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease

> **NCT03743636** · PHASE3 · COMPLETED · sponsor: **Northwestern University** · enrollment: 90 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DRUG:** Nicotinamide riboside
- **DRUG:** Resveratrol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03743636
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2023-05-23
- **Final completion:** 2023-05-23
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03743636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03743636, "Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03743636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*